Turnstone Biologics Corp. Revenue
Turnstone Biologics Corp. reported Revenue of $19.31 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2025-03-31
- Turnstone Biologics Corp. revenues for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Turnstone Biologics Corp. revenues for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Turnstone Biologics Corp. revenues for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Turnstone Biologics Corp. revenues for the quarter ending 2023-03-31 was $19.31M.
- Turnstone Biologics Corp. revenues for fiscal 2023 was $19.31M, a 73.66% decline from fiscal 2022.
- Turnstone Biologics Corp. revenues for fiscal 2022 was $73.30M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $19.31M 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $19.31M 10-Q · filed 2024-11-12 | $29.75M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $19.31M 10-Q · filed 2024-08-14 | $29.75M derived: sum of 3 quarters · filed 2024-08-14 | $39.97M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $19.31M 10-Q · filed 2024-05-13 | $29.75M derived: sum of 2 quarters · filed 2024-05-13 | $39.97M derived: sum of 3 quarters · filed 2024-05-13 | $81.89M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $10.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $20.67M derived: sum of 2 quarters · filed 2024-03-22 | $62.58M derived: sum of 3 quarters · filed 2024-03-22 | $73.30M 10-K · filed 2024-03-22 |
| 2022-09-30 | $10.22M 10-Q · filed 2023-11-13 | $52.13M derived: sum of 2 quarters · filed 2023-11-13 | $62.85M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $41.91M 10-Q · filed 2023-09-01 | $52.63M 10-Q · filed 2023-09-01 |